MedDataX Logo

Ketamine- Propofol Versus Pethidine- Propofol in ERCP

NCT02651792 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-04-29

No results posted yet for this study

Summary

The investigators aim to investigate the differences between ketamine propofol and pethidine propofol during ERCP in respect to endoscopist satisfaction.

Conditions

  • Sedation in ERCP

Interventions

DRUG

ketamine- propofol

1 mg x kg(-1) ketamine + 1.2 mg x kg(-1) propofol.

DRUG

pethidine- propofol

1.1 mg x kg(-1) pethidine + 1.2 mg x kg(-1) propofol for sedation induction

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mostafa S Abbas, MD · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Egypt

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651792 on ClinicalTrials.gov